NextGen Healthcare to be acquired by Thoma Bravo for $23.95 per share in cash

NextGen Healthcare announced that it has entered into a definitive agreement to be acquired by Thoma Bravo, a software investment firm. Upon completion of the transaction, NextGen Healthcare will become a privately held company. Under the terms of the agreement, NextGen Healthcare shareholders will receive $23.95 per share in cash. The per share purchase price represents a 46.4% premium to the company’s unaffected closing stock price on August 22 and a 39.2% premium to the 30-day volume-weighted average price for the period ending September 1. The transaction, which was approved unanimously by the NextGen Healthcare board of directors, is expected to close in the fourth calendar quarter of 2023, subject to customary closing conditions, including approval by NextGen Healthcare shareholders and the receipt of required regulatory approvals. The transaction is not subject to a financing condition. Upon completion of the transaction, NextGen Healthcare’s common stock will no longer be listed on any public stock exchange.